AACC Releases Guidelines on Use of Procalcitonin Tests
Tests for procalcitonin, a marker of infection, have only recently become available in the US, leading to uncertainty about their use, according to the AACC.
Thermo Fisher Licenses Procalcitonin Assay to Siemens Healthineers
Siemens' Atellica BRAHMS PCT assay received clearance from the US Food and Drug Administration on July 16, which the company announced in August.
BioMérieux Q2 Revenues Up 3 Percent
The firm attributed growth to a diversified geographic footprint and comprehensive offerings based on three key in vitro diagnostics technologies.
FDA Clears Roche's PCT Assay for Expanded Use
The FDA cleared Roche's Elecsys BRAHMS PCT electrochemiluminescence immunoassay for an expanded use to aid in antibiotic therapy decision-making.
Clinicians were surprised by a recent NEJM study that found that using procalcitonin assays did not reduce the use of antibiotics.